These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 32580133)

  • 1. Use of cannabis and its products among patients in a tertiary epilepsy center: A cross-sectional survey.
    Puteikis K; Mameniškienė R
    Epilepsy Behav; 2020 Oct; 111():107214. PubMed ID: 32580133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Australian nationwide survey on medicinal cannabis use for epilepsy: History of antiepileptic drug treatment predicts medicinal cannabis use.
    Suraev AS; Todd L; Bowen MT; Allsop DJ; McGregor IS; Ireland C; Lintzeris N
    Epilepsy Behav; 2017 May; 70(Pt B):334-340. PubMed ID: 28238865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marijuana use among patients with epilepsy at a tertiary care center.
    Kerr A; Walston V; Wong VSS; Kellogg M; Ernst L
    Epilepsy Behav; 2019 Aug; 97():144-148. PubMed ID: 31252269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knowledge, expectations and fears of cannabis use of epilepsy patients at a tertiary epilepsy center.
    von Wrede R; Moskau-Hartmann S; Amarell N; Elger CE; Helmstaedter C
    Epilepsy Behav; 2019 Oct; 99():106458. PubMed ID: 31419634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of artisanal and non-regulated cannabis-based products for the treatment of epilepsy in a low-income population.
    Espinosa-Jovel C; Riveros S; Acosta-Amaya A; García C
    Epilepsy Behav; 2024 Oct; 159():109942. PubMed ID: 39121749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The legal status of cannabis (marijuana) and cannabidiol (CBD) under U.S. law.
    Mead A
    Epilepsy Behav; 2017 May; 70(Pt B):288-291. PubMed ID: 28169144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Social factors in marijuana use for medical and recreational purposes.
    Szaflarski M; Sirven JI
    Epilepsy Behav; 2017 May; 70(Pt B):280-287. PubMed ID: 28132734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome.
    Hussain SA; Zhou R; Jacobson C; Weng J; Cheng E; Lay J; Hung P; Lerner JT; Sankar R
    Epilepsy Behav; 2015 Jun; 47():138-41. PubMed ID: 25935511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attitudes and knowledge about cannabis and cannabis-based therapies among US neurologists, nurses, and pharmacists.
    Szaflarski M; McGoldrick P; Currens L; Blodgett D; Land H; Szaflarski JP; Segal E
    Epilepsy Behav; 2020 Aug; 109():107102. PubMed ID: 32442891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabis and Endocannabinoid Signaling in Epilepsy.
    Katona I
    Handb Exp Pharmacol; 2015; 231():285-316. PubMed ID: 26408165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis and epilepsy.
    Thomas RH; Cunningham MO
    Pract Neurol; 2018 Dec; 18(6):465-471. PubMed ID: 30337476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marijuana Use in Epilepsy: The Myth and the Reality.
    Detyniecki K; Hirsch L
    Curr Neurol Neurosci Rep; 2015 Oct; 15(10):65. PubMed ID: 26299273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabis for the Treatment of Epilepsy: an Update.
    Gaston TE; Szaflarski JP
    Curr Neurol Neurosci Rep; 2018 Sep; 18(11):73. PubMed ID: 30194563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Pharmacological Basis of Cannabis Therapy for Epilepsy.
    Reddy DS; Golub VM
    J Pharmacol Exp Ther; 2016 Apr; 357(1):45-55. PubMed ID: 26787773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Historical perspective on the medical use of cannabis for epilepsy: Ancient times to the 1980s.
    Friedman D; Sirven JI
    Epilepsy Behav; 2017 May; 70(Pt B):298-301. PubMed ID: 28089286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impacts of potency, warning messages, and price on preferences for Cannabis flower products.
    Shi Y; Cao Y; Shang C; Pacula RL
    Int J Drug Policy; 2019 Dec; 74():1-10. PubMed ID: 31382201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy.
    Porter BE; Jacobson C
    Epilepsy Behav; 2013 Dec; 29(3):574-7. PubMed ID: 24237632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fewer specialists support using medical marijuana and CBD in treating epilepsy patients compared with other medical professionals and patients: result of Epilepsia's survey.
    Mathern GW; Beninsig L; Nehlig A
    Epilepsia; 2015 Jan; 56(1):1-6. PubMed ID: 25413126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoids in treatment-resistant epilepsy: A review.
    O'Connell BK; Gloss D; Devinsky O
    Epilepsy Behav; 2017 May; 70(Pt B):341-348. PubMed ID: 28188044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Path to the First FDA-Approved Cannabis-Derived Treatment and What Comes Next.
    Rubin R
    JAMA; 2018 Sep; 320(12):1227-1229. PubMed ID: 30193358
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.